Eton Pharmaceuticals (ETON) Net Cash Flow (2018 - 2025)

Eton Pharmaceuticals has disclosed Net Cash Flow across 8 years of filings, most recently posting -$11.2 million for Q4 2025.

• Net Cash Flow for Q4 2025 came in at -$11.2 million, down 109.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.0 million (up 270.58% YoY), and the FY2025 annual result was $11.0 million, up 270.58% from the prior year.
• Net Cash Flow came in at -$11.2 million for Q4 2025 at Eton Pharmaceuticals, down from $11.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $11.7 million in Q3 2025 to a low of -$11.2 million in Q4 2025.
• The 5-year median for Net Cash Flow is $663500.0 (2022), against an average of $197500.0.
• Across the five-year window, Net Cash Flow soared 22812.5% in 2022 and tumbled 680.79% in 2024, its largest moves.
• Eton Pharmaceuticals' Net Cash Flow stood at -$8.3 million in 2021, then soared by 135.25% to $2.9 million in 2022, then sank by 123.3% to -$682000.0 in 2023, then sank by 680.79% to -$5.3 million in 2024, then plunged by 109.93% to -$11.2 million in 2025.
• The last three Net Cash Flow figures came in at -$11.2 million (Q4 2025), $11.7 million (Q3 2025), and $8.0 million (Q2 2025), per Business Quant data.